{'fraction_non_alphanumeric': 0.021321961620469083, 'fraction_numerical': 0.017057569296375266, 'mean_word_length': 5.351351351351352, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines

In view of the inequitable distribution of COVID-19 vaccines, several initiatives have been discussed to waive respective patent rights. This article provides a fact-based multinational study on patent rights protecting BioNTech-Pfizer's vaccine BNT162b2. We conclude that although there actually is a vaccine shortage in many countries, patents cannot be blamed as the scapegoat for said situation.